Angiotensin-Converting Enzyme Inhibitor Dose Optimization and Its Associated Factors at Felege Hiwot Comprehensive Specialized Hospital, Bahir Dar, Ethiopia

INTRODUCTION: Angiotensin-converting enzyme inhibitors dose optimizations (ACEIs) are essential to boost the treatment outcome in heart failure patients (HF) with reduced ejection fraction. Therefore, the main purpose of this study was to evaluate dose optimization and associated factors of ACEIs am...

Descripción completa

Detalles Bibliográficos
Autores principales: Gelaye, Abebech Tewabe, Seid, Mohammed Assen, Baffa, Lemlem Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9272845/
https://www.ncbi.nlm.nih.gov/pubmed/35832662
http://dx.doi.org/10.2147/VHRM.S363051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9272845/
https://www.ncbi.nlm.nih.gov/pubmed/35832662
http://dx.doi.org/10.2147/VHRM.S363051

Ejemplares similares